Parkhurst NuVision fellow | Refractive, research, innovation, & education | Sharing ophthalmology as I understand it | Education, not advice |
Joined May 2021
- Tweets706
- Following195
- Followers6.4K
- Likes606
Matt Hirabayashi, MD retweeted
Go @EyeFlyMD!
"My biggest recommendation is considering moving beyond white-to-white."
Matt Hirabayashi, MD, shares pearls on ICL sizing and discusses the benefits these lenses offer patients with low #myopia.
#OcularSurgeryNews @EyeFlyMD
healio.com/news/ophthalmolog…
Matt Hirabayashi, MD retweeted
Artificial intelligence. A hot topic that is reshaping the world we live in. Explore its application in Ophthalmology in the episode below. @eyeSpace_ai @EyeFlyMD @GurpalVirdi
eyetube.net/podcasts/crst-th…
Thanks Joaquin De Rojas and to the BMC team for the support!
@YoungMDConnect
Matt Hirabayashi, MD retweeted
We have added the new enVista Aspire to IOLReference. Envista has such great distance corrected near vision this lens should enhance that even further.
#ophthalmology #ophthotwitter
Matt Hirabayashi, MD retweeted
The #EyeGuide has been updated to reflect the recent change in Altus Suite requirements ➡️no Casper test this application cycle!!!! 👻 #ophtho #match2024 #sfmatch
eyeflymd.com/wp-content/uplo…
Matt Hirabayashi, MD retweeted
@EyeFlyMD and Jella An discuss the factors to consider when selecting a premium #IOL option for #glaucoma patients.
Read more below👇🏼
theophthalmologist.com/subsp…
Matt Hirabayashi, MD retweeted
The newly available and FDA approved CT LUCIA 621 single piece has been added to the database.
#ophthalmology #ophthotwitter #MedTwitter
Matt Hirabayashi, MD retweeted
Happy to be at my first @YoungMDConnect conference! #MizzouStrong #YMDC2023 @EyeFlyMD @GurpalVirdi @sambarry
Matt Hirabayashi, MD retweeted
We are always staying current with the help of industry. As new information becomes available, we are graying out models that don't appear in current-year marketing material or are being phased out and may have limited availability.
#ophthalmology #ophthotwitter #medtwitter
Matt Hirabayashi, MD retweeted
Spherical Aberration of Cataractous Eyes and Its Relationship With Age, Ocular Biometry, and Various IOL Platforms @eyeflymd journals.healio.com/doi/10.3…
Matt Hirabayashi, MD retweeted
Hirabayashi et al review the median spherical aberration of the cataractous population, how it relates to biometry, and the theoretical effect of different IOL platforms @eyeflymd journals.healio.com/doi/10.3…
Matt Hirabayashi, MD retweeted
Check out this article in The Ophthalmologist! We have some major announcements coming up so stay tuned.
#Ophthalmology #ophthotwitter #MedTwitter @GurpalVirdi @EyeFlyMD
theophthalmologist.com/subsp…
Matt Hirabayashi, MD retweeted
Very excited to be a collaborator for @EyeFlyMD’s website! He has great resources for the match! Check it out here: eyeflymd.com/matching
Matt Hirabayashi, MD retweeted
Reminder: Android and web-based users can access the directory online by going to iolreference.com and selecting “Use Online”
#Ophthalmology #Ophthotwitter #MedTwitter
Matt Hirabayashi, MD retweeted
We had a wonderful first #Retina Grand Rounds on @Clubhouse with our hosts @GurpalVirdi and @EyeFlyMD! Thanks to everyone for joining our case on Retinitis Pigmentosa! #ophthotwitter
We hope to see everyone for our next Grand Rounds event soon!
